Literature DB >> 8070869

Use of transgenic mice for assessing the mutagenicity of 1,3-butadiene in vivo.

L Recio1, J A Bond, L J Pluta, S C Sisk.   

Abstract

We have examined the mutagenicity of 1,3-butadiene in vivo in transgenic mice constructed with lambda phage shuttle vectors that contain either lacZ or lacI as transgenes. Thus far, we have shown that butadiene is mutagenic to the lung of lacZ mice (CD2F1, 625 ppm butadiene, 6 h/day, 5 days) and to the bone marrow of lacI mice (B6C3F1, 62.5, 625, 1250 ppm butadiene, 6 h/day, 5 days/week, 4 weeks) exposed by inhalation to the same concentrations used previously in bioassays of the carcinogenicity of butadiene. Analysis of the DNA sequences of lacI mutants from the bone marrow of lacI mice demonstrated a shift in the spectrum of mutation from G:C base pairs in the control group to mutation at A:T base pairs in the exposed group. In addition, analysis of DNA sequences of mutations in three animals exposed to butadiene showed evidence of mutant clonal expansion in vivo. These results indicate that butadiene induces mutation in mouse tissues. Analysis of mutations at the level of DNA sequences is useful for examining the relationship between mutation and mutant frequencies in vivo and the spectrum of mutation in transgenic animals after exposures to carcinogens.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8070869

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


  2 in total

1.  Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test.

Authors:  Ulrich Wahnschaffe; Annette Bitsch; Janet Kielhorn; Inge Mangelsdorf
Journal:  J Carcinog       Date:  2005-01-27

2.  Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test.

Authors:  U Wahnschaffe; A Bitsch; J Kielhorn; I Mangelsdorf
Journal:  J Carcinog       Date:  2005-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.